Hoomans, Ties; Severens, Johan L.; van der Roer, Nicole; … - In: PharmacoEconomics 30 (2012) 3, pp. 219-227
Background:Background: In the Netherlands, decisions about the reimbursement of new pharmaceuticals are based on cost … substantiate the cost effectiveness of drugs that have therapeutic added value in comparison with existing ones through … costs and effects were correct. However, drug indication, form (i.e. cost utility/cost effectiveness) and time horizon of …